Skip to main content
OpenTrials
Completed

NCT Number: NCT00933725

Efficacy and Safety of Traditional Chinese Medicine Intervention for Women With Menopausal Syndrome

The purpose of this multiple-centered, randomized, controlled study is to investigate the efficacy and safety of a combination using herbs prescription and traditional Chinese medicine (TCM) emotion treatment in women with menopausal syndrome.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

41 year–60 year

Sex eligibility

Female

Study type

Interventional

Phase

Phase 3

Primary location

Foshan Hospital of Traditional Chinese Medicine, Foshan, Guangdong, China

Loading trial locations.

About this study

Menopausal syndrome is a high incident disease which is associated with great influence in women's health and quality of life. It involves physical discomforts and emotional symptoms. Traditional Chinese medicine (TCM) theory emphasizes treating physical and emotional symptoms simultaneously viewing one person as an entirety. Herbs prescription and TCM emotion treatment is effective and safe to treat women with menopausal syndrome in clinical practice.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Aged 41-60;
  • Amenorrhea for at least 6 months;
  • Menstruation dysfunction or cessation because of age or bilateral ovariectomy;
  • Hot flushes and night sweats symptoms;
  • Vaginal secretion decreased with or without dyspareunia;
  • Kupperman Index (KI) score ≥ 15;
  • Self-rating Anxiety Scale or Self-rating Depression Scale standard score >50,but <72(standard score= scale score ×1.25);
  • FSH ≥ 20 IU/L;
  • Thickness of endometrium ≤0.5cm if Amenorrhea for at least 12 months;or ≤1.5cm if Amenorrhea for 6 months to 12 months;
  • Meet the diagnosis criteria of TCM syndrome of liver stagnation and kidney deficiency.

Exclusion criteria

  • With malignant tumor in reproductive system;
  • With benign tumor in reproductive system and need surgery;
  • Malignant tumor in mammary gland;
  • Irregular vaginal bleeding for unknown reasons;
  • Thickness of endometrium ≥1.5cm by ultrasound examination;
  • Have used Sex hormone medicine or joined other clinical trials 3 months before;
  • Allergy;
  • Severe diseases (eg., of the cardiovascular, liver, kidney) or uncontrolled endocrine diseases (eg., diabetes mellitus, hyperthyreosis )
  • Severe psychiatric disease diagnosed by psychiatric physician;
  • Refuse informed consent.

Treatment and study plan

TCM intervention

Other

Drug: Particle of compound Chinese herbs(produced by San_jiu Medical & Pharmaceutical Limited Company, Guangzhou, Guangdong Province, China), mixing with boiled water, free of decoction, taken orally, twice a day, for two months.

One tablet placebo of Tibolone (provided by San_jiu Medical & Pharmaceutical Limited Company, Guangzhou, Guangdong Province, China, once every two days, taken orally, for two months.

Behavioral: TCM emotion treatment: made under the guide of TCM theory, administered by qualified TCM physician, for three times in two months.

Western intervention

Other

Drug: Tibolone, (produced by Oujianong corporation, Nanjing, China), 2.5mg, once every two days, taken orally, for two months; Particle placebo of compound Chinese herbs (produced by San_jiu Medical & Pharmaceutical Limited Company, Guangzhou, Guangdong Province, China), mixing with boiled water, free of decoction, taken orally, twice a day, for two months.

Behavioral: supportive psychotherapy, administered by qualified physician, for three times in two months.

Primary outcomes

  1. Kupperman index

    Time frame: 2 months

Secondary outcomes

  1. blood serum estradiol

    Time frame: 2 months

Sponsors and collaborators

Lead sponsor

Guangzhou University of Traditional Chinese Medicine

Other

Registry information

Official study title

Efficacy and Safety of Combined Treatment of Herbs and TCM Emotion Treatment for Women With Menopausal Syndrome: A Multiple-centered Randomized Controlled Trial

Important dates

Study start
2009
Primary completion
2011
Study completion
2011
First posted
Jul 7, 2009
Registry last updated
Jun 18, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.